Effects of Institutional Experience on Plan Quality in Stereotactic Radiotherapy Using HyperArc for Brain Metastases

被引:0
|
作者
Kihara, Sayaka [1 ,2 ]
Ohira, Shingo [1 ,3 ]
Kanayama, Naoyuki [1 ]
Ikawa, Toshiki [1 ]
Inui, Shoki [1 ]
Isono, Masaru [1 ]
Nitta, Yuya [1 ]
Ueda, Yoshihiro [1 ]
Nishio, Teiji [2 ]
Konishi, Koji [1 ]
机构
[1] Osaka Int Canc Inst, Dept Radiat Oncol, 3-1-69 Otemae,Chuo Ku, Osaka 5418567, Japan
[2] Osaka Univ, Grad Sch Med, Div Hlth Sci, Med Phys Lab, Osaka, Japan
[3] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan
来源
IN VIVO | 2025年 / 39卷 / 01期
关键词
Stereotactic radiosurgery; brain metastases; HyperArc; volumetric modulated arc therapy; linear accelerator; RADIOSURGERY;
D O I
10.21873/invivo.13819
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: HyperArc (HA) is an automated planning technique enabling single-isocenter brain stereotactic radiotherapy (SRT); however, dosimetric outcomes may be influenced by the planner's expertise. This study aimed to assess the impact of institutional experience on the plan quality of HA-SRT for both single and multiple brain metastases. Materials and Methods: Twenty patients who underwent HASRT for single metastasis between 2020 and 2021 comprised the earlier group, while those treated between 2022 and 2024 constituted the later group. For multiple metastases, 40 patients who received HA-SRT from 2020 2024 were divided into earlier and later treatment groups. Dosimetric parameters including gross tumor volume (GTV) doses (D98% and Dmean), volumes of the normal brain (Brain-GTV V25Gy and V30Gy), homogeneity index (HI), gradient index (GI), and total monitor unit (MU) were compared. A linear regression model was used to evaluate the effects of planning target volume (PTV) on volumes of normal brain via interaction between PTV volume and treatment era group (earlier vs. later). Results: The later group exhibited significantly higher D98% and Dmean values for both single and multiple metastases, while V25Gy and V30Gy and GI mean values were comparable. Consequently, mean HI and total MU values increased significantly. Both single and multiple metastases showed significant interaction between PTV volume and treatment era group. Conclusion: Enhanced dosimetric outcomes in the later group suggested that accumulated experience contributed to improve GTV and brain dose in HA SRT. Institutional experience is important to improve the plan quality for SRT even with automatic planning such as HA.
引用
收藏
页码:210 / 217
页数:8
相关论文
共 50 条
  • [1] What is the optimal isodose line for stereotactic radiotherapy for single brain metastases using HyperArc?
    Sagawa, Tomohiro
    Ikawa, Toshiki
    Ohira, Shingo
    Kanayama, Naoyuki
    Ueda, Yoshihiro
    Inui, Shoki
    Miyazaki, Masayoshi
    Konishi, Koji
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2024, 25 (09):
  • [2] HyperArc and RapidArc dosimetric comparison for resected brain metastases stereotactic radiotherapy
    Muni, R.
    Colleoni, P.
    Fortunato, M.
    Benfetima, M. I.
    Bianchi, C.
    Motta, M.
    Andreoli, S.
    Cretti, F.
    Filippone, F. R.
    Maffioletti, L.
    Piccoli, F.
    Vitali, E.
    Vukcaj, S.
    Rinaldi, G.
    Cazzaniga, L. F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1575 - S1576
  • [3] Hypofractionated stereotactic radiotherapy (HFSRT) for 50 brain metastases: Institutional experience
    Ciervide, R.
    Lopez, M.
    Hernando, O.
    Sanchez, E.
    Montero, A.
    Valero, J.
    Garcia-Aranda, M.
    Chen, X.
    Alonso, R.
    Alvarez, B.
    Acosta, A.
    Rubio, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S667 - S668
  • [4] Fractionated Stereotactic Radiotherapy with Helical Tomotherapy for Brain Metastases: A Mono-Institutional Experience
    Cuccia, Francesco
    D'Alessandro, Salvatore
    Carruba, Giuseppe
    Figlia, Vanessa
    Spera, Antonio
    Cespuglio, Daniela
    Mortellaro, Gianluca
    Iacoviello, Giuseppina
    Lo Casto, Antonio
    Tringali, Giovanni
    Craparo, Giuseppe
    Blasi, Livio
    Ferrera, Giuseppe
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (07):
  • [5] Difference in Radiotherapeutic Plan of HyperArc-Based and CyberKnife-Based Stereotactic Radiotherapy (SRT) Techniques for Multiple Brain Metastases
    Tsai, C. J.
    Ho, H. W.
    Yang, C. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E728 - E729
  • [6] Plan Quality Assessment of Fractionated Stereotactic Radiotherapy Treatment Plans in Patients With Brain Metastases
    Simon, Mihaly
    Papp, Judit
    Csiki, Emese
    Kovacs, Arpad
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Stereotactic Radiotherapy for Treatment of Brain Metastases: a monocentric experience
    Gonnelli, A.
    Montrone, S.
    Molinari, A.
    Pasqualetti, F.
    Paiar, F.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S462 - S462
  • [8] Stereotactic radiosurgery to brain metastases using Varian HyperArc in the Beatson Cancer Centre
    Kjartansdottir, O.
    Williamson, A.
    Patibandla, A.
    Currie, S.
    Carruthers, R.
    Chalmers, A.
    James, A.
    Nowicki, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S679 - S680
  • [9] Dosimetric advantage of HyperArc over an institutional RapidArc planning technique for stereotactic treatment of multiple brain metastases
    Basharat, Fateen
    Dekker, Kurtis
    Olding, Tim
    Alexander, Kevin
    Kerr, Andrew
    MEDICAL PHYSICS, 2024, 51 (08) : 5786 - 5786
  • [10] Multifraction stereotactic radiotherapy for brain metastases: initial experience.
    Heylen, S.
    Lambrecht, M.
    Defraene, G.
    Vanstraelen, B.
    Nulens, A.
    Tilea, L. Estera
    Daisne, J.
    Berkovic, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S871 - S872